All News


Europe’s IPO markets top €50B in 2005; surpass US

As expected, the IPO markets in Europe made their strongest showing in several years in 2005 and have even topped the amount of money raised in the U.S., according to figures released today by PricewaterhouseCoopers in London.

Lessons for universities

A new report from MIT suggests that universities should avoid concentrating too much on technology transfer.

India bullish on global clinical trial business opportunity

Time and money are driving the world’s pharmaceutical companies east for their clinical trials. With its huge population, new helpful regulations and growth outstripping China, India plans to become the world leader in the clinical research business by the end of the decade.

Sworn enemies unite against draft EU IP law

Sworn enemies within the technology and pharmaceutical industries are joining forces in a lobbying drive to persuade European Union lawmakers to change a draft law they say will stifle innovation in Europe by criminalising patent infringements, along with all forms of intellectual property infringements.

Sigma-Aldrich goes shopping

Lab-supply companies are normally in the business of selling things to scientists, rather than buying. But the new CEO of Sigma-Aldrich, one of the world's largest lab-supply firms, is shopping for new ideas, new partners - and new companies to invest in.

Edinburgh team deactivates cross-contaminating prions

Scientists at Edinburgh University have developed a new method for cleaning surgical instruments that entirely removes protein contamination, including the near-indestructible prions - the agents that cause mad cow disease